# Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life

> **NCT03987152** · PHASE3 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 75 (estimated)

## Conditions studied

- Vascular Malformations

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT03987152
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-18
- **Primary completion:** 2021-09-18
- **Final completion:** 2023-03-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2021-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03987152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03987152, "Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03987152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*